| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 415.3K | $30.85M | -7,500 | |
| VP | 141.5K | $10.51M | - | |
| Other | 87.3K | $6.49M | - | |
| Dir | 75.2K | $5.59M | - | |
| CFO | 70.1K | $5.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Callos Andrew45 | EVP, Chief Commercial Officer | Sell | 7,449 | $66.02 | $491,782.98 | -11.3% | - | - | |
| Apr 15, 2026 | Blum Robert I51 | President &CEO | Sell | 7,500 | $65.38 | $490,350.00 | -1.8% | - | - | |
| Mar 17, 2026 | Blum Robert I51 | President &CEO | Sell | 36,601 | $62.15 | $2,274,752.15 | -4.0% | - | - | |
| Jan 5, 2026 | Callos Andrew45 | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $60.28 | $904,200.00 | -22.9% | +6.0% | - | |
| Jan 2, 2026 | Callos Andrew45 | EVP, Chief Commercial Officer | Sale+OE | 1,798 | $62.62 | $112,584.77 | -1.8% | +8.1% | - | |
| Dec 29, 2025 | Callos Andrew45 | EVP, Chief Commercial Officer | Sell | 1,809 | $62.44 | $112,953.96 | -3.4% | +2.0% | - | |
| Dec 22, 2025 | Wierenga Wendell | Director | Sale+OE | 20,000 | $66.14 | $1,322,800.00 | -38.1% | -7.1% | - | |
| Dec 16, 2025 | Malik Fady Ibraham56 | EVP Research &Development | Sale+OE | 2,200 | $61.24 | $134,728.00 | -1.6% | -1.9% | - | |
| Dec 8, 2025 | Callos Andrew45 | EVP, Chief Commercial Officer | Sale+OE | 1,042 | $65.96 | $68,730.32 | -2.0% | -2.7% | - | |
| Dec 5, 2025 | Callos Andrew45 | EVP, Chief Commercial Officer | Sale+OE | 52,486 | $65.95 | $3,461,451.70 | -50.9% | -5.3% | - |